Use of synchronization induced by cyclophosphamide in a methylcholanthrene sarcoma with circadian proliferation to rational sequential chemotherapy
- PMID: 1240011
Item in Clipboard
Use of synchronization induced by cyclophosphamide in a methylcholanthrene sarcoma with circadian proliferation to rational sequential chemotherapy
Biomedicine.
.
Abstract
Owing to the circadian activity of tumoral proliferation, cyclophosphamide (CPA) morning injection exerts, on a methylcholanthrene induced sarcoma, a preferential oncostatic effect. This morning injection is followed by a temporary inhibition of mitoses preceding a high mitotic peak, explained by chemo-induced synchronization of tumor cells. Whereas single vinblastine (VLB) administration has no antitumoral effect, an injection of VLB during the described peak is able to improve oncostatic effect of cyclophosphamide. Moreover, the VLB administration at the same moment as CPA suppresses antineoplastic activity of the latter.
Similar articles
-
[Effect of the rhythm of cyclophosphamide administration on its antitumor action and on the immune response of mice with methylcholanthrene-induced sarcoma].Biull Eksp Biol Med. 1974 Jul;78(7):87-90. Biull Eksp Biol Med. 1974. PMID: 4451721 Russian. No abstract available.
-
[Sequential chemotherapy based on the hypothesis of a circadian rhythm of tumor proliferation].Nouv Presse Med. 1975 Nov 8;4(38):2709-12. Nouv Presse Med. 1975. PMID: 1105421 Clinical Trial. French.
-
[Diurnal variations in the response of cells to factors altering mitotic activity].Usp Sovrem Biol. 1978 Sep-Oct;86(2):216-26. Usp Sovrem Biol. 1978. PMID: 364862 Review. Russian. No abstract available.
-
[Influence of circadian rhythm of cell division on the efficacy of cyclophosphamide on sarcoma induced by methylcholanthrene].C R Acad Hebd Seances Acad Sci D. 1973 Mar 26;276(13):2105-8. C R Acad Hebd Seances Acad Sci D. 1973. PMID: 4204289 French. No abstract available.
-
[Which methods to minimize the time factor are substantiated by the evidence, which are unproven?].Strahlenther Onkol. 2000 Oct;176(10):472-4. doi: 10.1007/pl00002313. Strahlenther Onkol. 2000. PMID: 11068593 Review. German.
Cited by
-
Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.Cancer Chemother Pharmacol. 1981;6(2):175-81. doi: 10.1007/BF00262339. Cancer Chemother Pharmacol. 1981. PMID: 7307235
-
Sequential chemotherapy and circadian rhythm in human solid tumours. A randomised trial.Cancer Chemother Pharmacol. 1979;3(3):197-202. doi: 10.1007/BF00262422. Cancer Chemother Pharmacol. 1979. PMID: 393429 Clinical Trial.